590 related articles for article (PubMed ID: 31511046)
1. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
2. Musashi-2 (MSI2) promotes neuroblastoma tumorigenesis through targeting MYC-mediated glucose-6-phosphate dehydrogenase (G6PD) transcriptional activation.
Jiang P; Zhang T; Wu B; Li X; Fu M; Xu B
Med Oncol; 2023 Oct; 40(11):332. PubMed ID: 37843625
[TBL] [Abstract][Full Text] [Related]
3. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.
Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
Bioengineered; 2022 May; 13(5):12115-12126. PubMed ID: 35546072
[TBL] [Abstract][Full Text] [Related]
4. LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis.
Dorneburg C; Fischer M; Barth TFE; Mueller-Klieser W; Hero B; Gecht J; Carter DR; de Preter K; Mayer B; Christner L; Speleman F; Marshall GM; Debatin KM; Beltinger C
Clin Cancer Res; 2018 Nov; 24(22):5772-5783. PubMed ID: 29925504
[No Abstract] [Full Text] [Related]
5. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
[TBL] [Abstract][Full Text] [Related]
6. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma.
Duan J; Bao X; Ma X; Zhang Y; Ni D; Wang H; Zhang F; Du Q; Fan Y; Chen J; Wu S; Li X; Gao Y; Zhang X
PLoS One; 2017; 12(1):e0169852. PubMed ID: 28076379
[TBL] [Abstract][Full Text] [Related]
8. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
10. The long noncoding RNA LINC00200 promotes the malignant progression of MYCN-amplified neuroblastoma via binding to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) to enhance the stability of Zic family member 2 (ZIC2) mRNA.
Chen J; Sun M; Huang L; Fang Y
Pathol Res Pract; 2022 Sep; 237():154059. PubMed ID: 35969939
[TBL] [Abstract][Full Text] [Related]
11. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
[TBL] [Abstract][Full Text] [Related]
12. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
Li J; Kretzner L
Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
[TBL] [Abstract][Full Text] [Related]
13. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
14. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.
Lin LL; Huang CC; Wu CL; Wu MT; Hsu WM; Chuang JH
Lab Invest; 2016 Jul; 96(7):719-30. PubMed ID: 27183205
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma.
Chen Y; Liu J; Geng N; Feng C
Int J Biol Markers; 2020 Jun; 35(2):56-65. PubMed ID: 32339054
[TBL] [Abstract][Full Text] [Related]
18. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
[TBL] [Abstract][Full Text] [Related]
19. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
20. The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma.
Hoebeeck J; Vandesompele J; Nilsson H; De Preter K; Van Roy N; De Smet E; Yigit N; De Paepe A; Laureys G; Påhlman S; Speleman F
Int J Cancer; 2006 Aug; 119(3):624-9. PubMed ID: 16506218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
